E156 Micro-Paper · Africa Clinical Trials

Stroke Research Void

Stroke kills more young Africans than in any other region, with a median age of ...

Africa Trials
232
US Trials
2,409
Gap Ratio
10x
Nations
54
Africa hosted 232 stroke trials versus 2,409 in the United States, a 10-fold disparity in research investment.
Stroke Research Void by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Regional Comparison Africa US Europe 0 1000 2000 3000
Enrollment Distribution Africa Reference 10000 20000 30000 40000 50000
No data
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Research Profile Volume Growth Phase3 Complete Diversity
No data
Growth 2010-2026 Before After Africa 0 0 US 0 0 Europe 0 0
Why It Matters

Stroke kills more young Africans than in any other region, with a median age of onset a decade earlier than in Europe, yet stroke trial infrastructure is virtually nonexistent.

In the burden-versus-investment landscape of African health research, does the distribution of stroke trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Bayesian posterior trial rate as the primary estimand using registry metadata for each nation. Africa hosted 232 stroke trials (1.0% of its portfolio) compared to 2,409 in the United States, yielding a 0.0-fold disparity in per-population investment. Shannon entropy of the trial distribution was 2.46 bits, confirming substantial concentration beyond random variation. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is limited by the use of a single registry and the absence of non-English trial databases.
Question

In the burden-versus-investment landscape of African health research, does the distribution of stroke trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the Bayesian posterior trial rate as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 232 stroke trials (1.

Interpretation

0% of its portfolio) compared to 2,409 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

Shannon entropy of the trial distribution was 2.

Extra

46 bits, confirming substantial concentration beyond random variation.

Extra

These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.

Extra

Interpretation is limited by the use of a single registry and the absence of non-English trial databases.